RubrYc Therapeutics is Drug Discovery in United States that focus on decode protein interactions business. Founded in 2017. They cover business area such as developer, novel biotherapeutic technology, chemistry, computation, antibody-base drug, epitope selectivity, datum, biological science, molecular library synthesis, bio-therapeutic partner, preclinical antibody discovery, current drug discovery paradigm.
2017
( 7 years old in 2024 )
Decode Protein Interactions
-
733 Industrial Road
San Carlos, CA 94070
United States
Private
developernovel biotherapeutic technologychemistrycomputationantibody-base drugepitope selectivitydatumbiological sciencemolecular library synthesisbio-therapeutic partnerpreclinical antibody discoverycurrent drug discovery paradigm
* We use standard office opening hours in near RubrYc Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
RubrYc Therapeutics is Drug Discovery business from United States that founded in 2017 (7 years old in 2024), RubrYc Therapeutics business is focusing on Decode Protein Interactions.
RubrYc Therapeutics headquarter office and corporate office address is located in 733 Industrial Road San Carlos, CA 94070 United States.
RubrYc Therapeutics was founded in United States.
In 2024, RubrYc Therapeutics is currently focus on decode protein interactions sector.
Above is snippet of Google Trends for "decode protein interactions" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with RubrYc Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
